About Deep Biologics
Deep Biologics is a company based in Toronto (Canada) founded in 2020 by Shraddha Dubey and Dea Shahinas. The company has 3 employees as of December 31, 2024. Deep Biologics operates in a competitive market with competitors including Benchsci, Antiverse, Nona Biosciences, EPITOPIC and AB-Pred, among others.
- Headquarter Toronto, Canada
- Employees 3 as on 31 Dec, 2024
- Founders Shraddha Dubey, Dea Shahinas
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
3
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Deep Biologics
Detailed funding history for Deep Biologics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Deep Biologics
Investment portfolio details for Deep Biologics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Deep Biologics
Detailed financials for Deep Biologics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Deep Biologics Comparisons
Peer comparison for Deep Biologics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Deep Biologics
Deep Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benchsci, Antiverse, Nona Biosciences, EPITOPIC and AB-Pred, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
|
| Locked | Locked | Locked |
An AI platform for antibody drug discovery is provided.
|
|
| Locked | Locked | Locked |
Offers antibody discovery, development, and engineering services for biotherapeutics.
|
|
| Locked | Locked | Locked |
Provider of cell therapy and antibody services
|
|
| Locked | Locked | Locked |
Provides antibody prediction software for specialized applications.
|
Detailed competitors of Deep Biologics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Deep Biologics
Complete news archive for Deep Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deep Biologics
Deep Biologics was founded in 2020.
Deep Biologics is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Dea Shahinas is the current CEO of Deep Biologics. They have also founded this company.
As of Dec 31, 2024, the latest employee count at Deep Biologics is 3.
Deep Biologics was founded in 2020 in Toronto, Canada, within the biotechnology sector. An AI-based platform is provided for antibody mining and screening in research and development. Protein libraries are screened using AI to identify target proteins for diagnostic antibodies. Hit predictions are supported, and databases are processed to match peptides and antibodies against specific targets. Operations focus on enhancing RD efficiency in antibody discovery.